TABLE 1.
Enrolled patients (N = 22) | |
---|---|
Age (years) | |
Mean (SD) | 56.0 (8.8) |
Range | 39–69 |
Reconstruction, n (%) | |
None | 12 (54.5) |
Saline implant | 1 (4.5) |
Silicone implant | 8 (36.4) |
Flap | 1 (4.5) |
Radiation dose to chest wall, n (%) | |
4,800 cGY, 24 fractions | 1 (4.5) |
5,000 cGY, 25 fractions | 11 (50.0) |
5,040 cGY, 28 fractions | 7 (31.8) |
Information not available | 3 (13.6) |
Acute radiation dermatitis grade, n (%)a | |
Grade 1 | 4 (18.2) |
Grade 2 | 10 (45.5) |
Grade 3 | 5 (22.7) |
Grade 4 | 2 (9.1) |
No acute radiation dermatitis reported | 1 (4.5) |
Time between RT and RIBT appearance n (%) | |
< 6 months | 8 (36.4) |
6–12 months | 8 (36.4) |
>1–2 years | 2 (9.1) |
> 2 years | 3 (13.6) |
Not reported | 1 (4.5) |
Years since RT | |
Mean (SD) | 7.7 (4.1) |
Range | 2–17 |
Clinical RIBT severity score | |
Mean (SD) | 7.0 (1.6) |
Range | 3–10 |
Telangiectasia location, n (%) | |
Chest wall/breast | 2 (9.1) |
Chest wall/breast and axilla | 3 (13.6) |
Chest wall/breast and décolletage | 4 (18.2) |
Chest wall/breast, axilla, and décolletage | 13 (59.1) |
SD, standard deviation; RT, radiation therapy; RIBT, radiation-induced breast telangiectasias.
Grade 1, faint erythema or dry desquamation; Grade 2, moderate to brisk erythema, patchy moist desquamation, mostly confined to skin folds and creases, moderate edema; Grade 3, moist desquamation other than skin folds and creases, bleeding induced by minor trauma or abrasion; Grade 4, skin necrosis or ulceration of full thickness dermis, spontaneous bleeding from involved site.